Bookmark

Add to MyYahoo RSS

OrthoClinical Diagnostics News

News on OrthoClinical Diagnostics (Ticker: JNJ) continually updated from thousands of sources around the net.

Thursday Sep 11 | Courier News

Expanded Rutgers career fair offers more opportunitiesExpanded...

Expanded Rutgers career fair offers more opportunities Rutgers Career Services' Career & Intership Mega Fair has expanded to two days with a record 300 employers. Check out this story on mycentraljersey.com: http://mycj.co/1tDnojO Rutgers students and alumni recommended that their peers attend the university's expanded Career & Internship Mega Fair, which continues Friday on the Busch Campus.

Comment?

Related Topix: Rutgers University, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Scios, Medical Equipment

Wed Sep 10, 2014

Seeking Alpha

Johnson & Johnson's Management Presents at 2014 Morgan Stanley Health Care Conference

Good morning. It's a, sorry. So find your seats here. It's our pleasure to have this year this morning management team members from Johnson & Johnson, specifically the Chief Financial Officer, Dominic Caruso; so Stan Panasewicz, Senior Director of Investor Relations, obviously, you maybe know Stan.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Medical Equipment, VisionCare Ophthalmic Technologies, Startups, Scios

Daily Kos

A House of Cards for Pelvic Mesh?

A House of Cards: How consecutive multi-million dollar verdicts spell the beginning of the end for the pelvic mesh industry Last Friday, a West Virginia jury awarded $3.27 million to an Illinois woman in her case against industry giant Johnson & Johnson over her pelvic mesh implant, a controversial medical device that allegedly resulted in permanent nerve damage, chronic pain, and caused the former athlete trouble with walking, among other symptoms.

Comment?

Related Topix: Healthcare Law, Law, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Medical Equipment

Wed Sep 03, 2014

Investor's Business Daily

Sharper Focus Pays Dividends At Johnson & Johnson

Judging by its Q2 earnings report, the strategy seems to be working. In July, the company and Dow industrials component reported strong second-quarter earnings.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Medical Equipment, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

Business World

Google is Ireland's No 1 exporter

Google Ireland is Ireland's top exporter with Microsoft coming in at No 2, according to the Top 250 Exporters in Ireland and Northern Ireland from the Irish Exporters Association and Investec.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

Seeking Alpha

Johnson & Johnson Facing New Lawsuits On Pinnacle Hips

Johnson & Johnson is facing a new round of lawsuits over its DePuy unit's Pinnacle line of metal-on-metal hip implants blamed for poisoning patients.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

Tue Sep 02, 2014

Bloomberg

J&J's Pinnacle Hips Face First Trial on Poisoned Patients

Johnson & Johnson , which set aside $2.5 billion last year to resolve claims that 8,000 of its artificial hips were defective, faces a new round of lawsuits over another line of hip implants blamed for poisoning patients.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, DePuy Orthopaedics, Medical Equipment

The Columbus Dispatch

IBM's Watson moves from - Jeopardy!' to analyzing scientific research

Scott Spangler, principal data scientist for IBM Watson Innovations, demonstrates how its cognitive technology can display connections in scientific literature and drug information.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

Mon Sep 01, 2014

TheAlternativePress.com

Mendham Resident Pursues Lifelong Dream as Suspense/Thriller Novelist

In the neighboring town of Mendham, resident Bill Powers went from leading groups of scientists in the United States, Europe, and Asia, to pursuing his passion of being a fictional author.

Comment?

Related Topix: Mendham, NJ, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Medical Equipment

Thu Aug 28, 2014

Reuters

Johnson & Johnson to seek buyer for medical device maker unit -WSJ

Johnson & Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Medical Equipment, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

Salt Lake Tribune

IBM's Watson goes from Jeopardy! to J&J scientist

New York a IBM wants you to know that its Watson technology can do more than win "Jeopardy!": It can now help accelerate scientific research and discoveries.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Medical Equipment

Tue Aug 26, 2014

WebWire

ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC.

ViaCyte, Inc., a privately held regenerative medicine company announced that it has entered into a Rights Agreement with Janssen Research & Development LLC , one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

Mon Aug 25, 2014

GuruFocus.com

Here's Why Johnson & Johnson Is a Good Investment at 52-Week Highs

Johnson & Johnson is appreciating a decent time in 2014, liking 10% and beating the more extensive market so far.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

Mon Aug 18, 2014

The Motley Fool

3 Reasons Johnson & Johnson Stock Could Rise

For the quarter, Johnson & Johnson delivered impressive revenue growth of 9.1% year-over-year.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

•••
•••
•••
•••

Woodbridge Jobs

•••
•••
•••
•••